Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma

References

• Pellerito C, Morana O, Ferrante F, et al. Synthesis, chemical characterization, computational studies and biological activity of new DNA methyltransferases (DNMTs) specific inhibitor. Epigenetic regulation as a new and potential approach to cancer therapy. J Inorg Biochem. 2015;150:18–27.
   PubMed Web of Science ®Google Scholar
• Ma JZ, Yang F, Zhou CC, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6 -methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65(2):529–543.
   PubMed Web of Science ®Google Scholar
• Wang S, Chai P, Jia R, et al. Novel insights on m6A RNA methylation in tumorigenesis: a double-edged sword. Mol Cancer. 2018;17(1): 101. Published 2018 Jul 21.
   PubMed Web of Science ®Google Scholar
• He L, Li J, Wang X, et al. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. J Cell Mol Med. 2018;22(10):4630–4639.
   PubMed Web of Science ®Google Scholar
• Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Invest. 2016;126(8):2775–2782.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou L, Wang Y. ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma. Cancer Cell Int. 2020;20:34.
   PubMed Web of Science ®Google Scholar
• Zhao E, Chen S, Dang Y. Development and external validation of a novel immune checkpoint-related gene signature for prediction of overall survival in hepatocellular carcinoma. Front Mol Biosci. 2021;7:620765.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang S, Dai W, et al. A comprehensive prognostic and immune analysis of SLC41A3 in pan-cancer. Front Oncol. 2021;10:586414.
   PubMedGoogle Scholar
• Wang Z, Jensen MA, Zenklusen JC. A practical guide to the cancer genome atlas (TCGA). Methods Mol Biol. 2016;1418:111–141.
   PubMedGoogle Scholar
• Mazzaferro V, Citterio D, Bhoori S, et al. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial [published correction appears in Lancet Oncol. 2020 Aug;21(8):e373. Lancet Oncol. 2020;21(7):947–956.
   PubMed Web of Science ®Google Scholar
• Dai D, Wang H, Zhu L, et al. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis. 2018;9(2):124.
   PubMed Web of Science ®Google Scholar
• Li Y, Qi D, Zhu B, et al. Analysis of m6A RNA methylation-related genes in liver hepatocellular carcinoma and their correlation with survival. Int J Mol Sci. 2021;22(3):1474.
   PubMed Web of Science ®Google Scholar
• Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–1307.
   PubMed Web of Science ®Google Scholar
• Alarcón CR, Goodarzi H, Lee H, et al. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell. 2015;162(6):1299–1308.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Li Q, Ni Y, Zhang L, et al. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther. 2021;6(1):76.
   PubMed Web of Science ®Google Scholar
• Sun L, Gao M, Qian Q, et al. Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish. Sci Total Environ. 2021;770:145285.
   PubMed Web of Science ®Google Scholar
• Liu H, Lan T, Li H, et al. Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR. Theranostics. 2021;11(3):1396–1411.
   PubMed Web of Science ®Google Scholar
• Zhou T, Li S, Xiang D, et al. m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduct Target Ther. 2020;5(1):296.
   PubMed Web of Science ®Google Scholar
• He RZ, Jiang J, Luo DX. The functions of N6-methyladenosine modification in lncRNAs. Genes Dis. 2020;7(4):598–605.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Cui Y, et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res. 2009;69(12):5194–5201.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang S. CKLF-Like MARVEL transmembrane domain-containing member 3 (CMTM3) inhibits the proliferation and tumorigenisis in hepatocellular carcinoma cells. Oncol Res. 2017;25(2):285–293.
   PubMed Web of Science ®Google Scholar
• Liu Z, Lu Z, Jing R, et al. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice. Theranostics. 2019;9(14):4006–4018.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ma L, Goswami S, et al. Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma. Oncoimmunology. 2019;8(4):e1571388.
   PubMed Web of Science ®Google Scholar
• Long J, Wang A, Bai Y, et al. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 2019;42:363–374.
   PubMed Web of Science ®Google Scholar
• Wu C, Lin J, Weng Y, et al. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma. J Clin Invest. 2020;130(9):4679–4693.
   PubMed Web of Science ®Google Scholar
• Gil-García B, Baladrón V. The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma [published correction appears in biol cell. 2016 Apr;108(4):113]. Biol Cell. 2016;108(2):29–40.
   PubMed Web of Science ®Google Scholar
• Meurette O, Mehlen P. Notch signaling in the tumor microenvironment. Cancer Cell. 2018;34(4):536–548.
   PubMed Web of Science ®Google Scholar
• Liu N, Zhou KI, Parisien M, et al. N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Res. 2017;45(10):6051–6063.
   PubMed Web of Science ®Google Scholar
• Patil DP, Chen CK, Pickering BF, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369–373.
   PubMed Web of Science ®Google Scholar
• Langhans B, Nischalke HD, Krämer B, et al. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma. Cancer Immunol Immunother. 2019;68(12):2055–2066.
   PubMed Web of Science ®Google Scholar